Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

Sanofi promotes global head of diabetes to expand role

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

Appointment
androgel

AbbVie hit with $140m fine over fraudulent marketing of Androgel

October 6, 2017
Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …

News
bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017
Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

News
aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

News

Merck KGaA promotes from within new MEA head

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …

Appointment
culture

Gonorrhoea is just the tip of the antimicrobial resistance iceberg

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …

Feature
meeker_david_2015_004low_0

KSQ Therapeutics emerges from shadows, with former Genzyme CEO at helm

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meeker, KSQ Therapeutics, biotech, drugs, pharma, pharmaceutical

KSQ Therapeutics has been known of for the last two years, when it was originally founded, but now it has …

Appointment
fpr4et-xlarge_trans_nvbqzqnjv4bqrqsyshnmi5jqhkavocpkgbkoqxwcrp1qzr8w2tfjptk

England set to adopt opt-out organ donation

October 5, 2017
Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …

News
ema_interior

57% of cancer drugs uses approved by EMA show no benefit

October 5, 2017
Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical

A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …

News
mylan_building_3

Mylan receives shock approval of Teva blockbuster

October 5, 2017
Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …

News
amgen_hq

CytomX scores deal with Amgen worth potential $1.5bn

October 4, 2017
Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical

CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …

News
cholera_infection_map

Global campaign to reduce cholera deaths by 90%

October 4, 2017
Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …

News
shire_image

Shire takes fight to Allergan over dry-eye drug

October 4, 2017
Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …

News

Bavarian Nordic seals $539 million vaccine deal

October 3, 2017
Manufacturing and Production BARDA, Bavarian Nordic, biotech, drugs, pharma, pharmaceutical

Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to …

News
flu_vaccine

‘Universal flu vaccine’ to be trialed this winter

October 3, 2017
Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025